These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 2491121)
21. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women. Josse RG CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542 [TBL] [Abstract][Full Text] [Related]
22. [The endocrinological and physiological changes in menopause]. Huhtaniemi I Duodecim; 1996; 112(12):1043-51. PubMed ID: 10593004 [No Abstract] [Full Text] [Related]
23. [Estrogen replacement therapy in menopause]. Lanchares JL An Med Interna; 1991 Dec; 8 Suppl 3():35-42. PubMed ID: 1793790 [No Abstract] [Full Text] [Related]
24. Is there a case for targeting hormone replacement therapy for osteoporosis at the menopause? Stevenson JC Osteoporos Int; 1998; 8 Suppl 1():S47-50. PubMed ID: 9682798 [No Abstract] [Full Text] [Related]
25. Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women. Romero M Adv Nurse Pract; 2002 Nov; 10(11):47-8, 51-2. PubMed ID: 12478948 [No Abstract] [Full Text] [Related]
26. Hormone replacement therapy: the right choice for your patient? Leong SL; Erickson DR; Pees RC J Fam Pract; 2005 May; 54(5):428-36. PubMed ID: 15865901 [No Abstract] [Full Text] [Related]
27. [Comparative evaluation of oral versus non-oral hormonal treatments in menopause]. Sitruk-Ware R J Gynecol Obstet Biol Reprod (Paris); 1996; 25(7):688-93. PubMed ID: 8991902 [TBL] [Abstract][Full Text] [Related]
28. [Progestins and osteoporosis. Does progestin contribute to the effectiveness of estrogen replacement therapy in menopause?]. Lopes P Rev Fr Gynecol Obstet; 1995; 90(5-6):307-8. PubMed ID: 7569595 [No Abstract] [Full Text] [Related]
29. [Hormone substitution in climacteric. Position of the German Menopause Society]. Schneider HP; Kuhl H; Dören M; Hesch D Zentralbl Gynakol; 1995; 117(6):B1-4. PubMed ID: 7645352 [No Abstract] [Full Text] [Related]
31. The rationale for low-dose hormonal therapy. Lobo RA Endocrine; 2004 Aug; 24(3):217-21. PubMed ID: 15542888 [TBL] [Abstract][Full Text] [Related]
32. [Menopause in women--hormonal replacement therapy]. Kulikowski M; Tomaszewska I Pol Tyg Lek; 1995 Nov; 50(44-47):5-9. PubMed ID: 8643429 [No Abstract] [Full Text] [Related]
33. Postmenopausal osteoporosis and hormone replacement therapy. Gambacciani M; Vacca F Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435 [TBL] [Abstract][Full Text] [Related]
34. [Therapy of climacteric disorder with cefakliman]. Sirakov M; Ivanov S Akush Ginekol (Sofiia); 2004; 43 Suppl 3():51-3. PubMed ID: 15673032 [No Abstract] [Full Text] [Related]
35. [Current status of estrogen and gestagen substitution in peri and postmenopause]. Birkhäuser M Praxis (Bern 1994); 1997 Jan; 86(5):125-8. PubMed ID: 9064729 [No Abstract] [Full Text] [Related]
36. [Osteoporosis in menopause: prevention and management]. Paran D; Elkayam O; Yaron M; Caspi D Harefuah; 1999 Mar; 136(6):483-8. PubMed ID: 10914269 [No Abstract] [Full Text] [Related]
37. [Hormone replacement therapy and breast cancer--any news?]. Holli K Duodecim; 1999; 115(2):101-2. PubMed ID: 11830839 [No Abstract] [Full Text] [Related]
38. The risks and benefits of long-term estrogen replacement therapy. Barrett-Connor EL Public Health Rep; 1989; 104 Suppl(Suppl):62-5. PubMed ID: 2517703 [TBL] [Abstract][Full Text] [Related]
39. Update: the latest on hormone replacement therapy. Packin GS J Am Osteopath Assoc; 2000 Oct; 100(10 Su Pt 1):S2-5. PubMed ID: 11105456 [TBL] [Abstract][Full Text] [Related]
40. [Menopause and hormone therapy]. Rüedi B Rev Med Suisse Romande; 1989 Nov; 109(11):885-7. PubMed ID: 2595161 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]